Concepedia

Tyler F. Stewart

TF

Statistics

Publications

29

Citations

1.4K

H-Index

23

Active since

2016

Affiliations

University of California San Diego(Current)

UC San Diego Health System

University of California, Los Angeles

University of Utah

University Hospitals Seidman Cancer Center

Tyler F. Stewart is an author at University of California San Diego specializing in oncology, medicine, and urology.

ORCID

Publications per year

2016–2024

29

Publications

29

Bladder Cancer, Version 3.2024

Thomas W. Flaig, Philippe E. Spiess, Michael Abern et al. · Journal of the National Comprehensive Cancer Network · 2024 · 236 citations · Full text

, , +12

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Ferdinandos Skoulidis, Haniel A. Araújo, Minh Truong et al. · Nature · 2024 · 155 citations · Full text

, , +17

Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors

Anita Gul, Tyler F. Stewart, Charlene Mantia et al. · Journal of Clinical Oncology · 2020 · 97 citations · Full text

, , +17

The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma

Anna Truini, Jacqueline H. Starrett, Tyler F. Stewart et al. · Clinical Cancer Research · 2019 · 64 citations · Full text

, , +16

A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors

Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos et al. · European Urology Oncology · 2021 · 62 citations · Full text

, , +16

1–5 of 29